Skip to content

Neogen NEOG Finance Lease Liabilities

Finance Lease Liabilities at other companies

Zoetis logo
ZoetisZTS
$6M-14.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$8.6M-4.4%
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
$255M
Opko Health logo
Opko HealthOPK
$3.01M-20.9%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$10.63M-63.4%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO

Other financials

Income statement

See full
Revenue$211.2M-4.4%
Gross profit$99.0M-10.2%
Operating income-$3.3M-161%
Net income-$17.0M-56.0%
EPS (diluted)-$0.08-60.0%

Balance sheet

See full
Cash & equivalents$159.9M+25.2%
Total debt$793.3M-11.2%
Total equity$2.1B-21.0%
Total assets$3.4B-16.8%

Cash flow

See full
Operating cash flow$22.7M+16.7%
CapEx$11.6M-64.7%
Free cash flow$11.1M+182%

Valuation

See full
Market cap$2B+93.1%
Enterprise value$2.63B+45.5%
P/S2.3×+1.1×

Profitability

See full
Gross margin45.2%-3.6pp
Operating margin-73.1%+77.7pp
Net margin-69.9%+30.8pp
FCF margin-14%

Returns & leverage

See full
Return on equity-25.6%+28.8pp
Debt / equity0.4×0.0×
Current ratio3.9×0.0×

Where this comes from

Reported directly by Neogen in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiability.

The official record: Neogen’s 10-K, filed July 30, 2025, on SEC EDGAR. View the filing →

Ask your AI about Neogen's finance lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neogen's finance lease liabilities?
Neogen (NEOG) reported finance lease liabilities of $2.43M in Q1 2025.
What does finance lease liabilities mean?
Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.